Dr Alice M Turner MBChB (Hons), MRCP, PGCE (MedEd), PhD

Dr Alice Turner

Institute of Applied Health Research
Professor of Respiratory Medicine
Honorary Consultant Respiratory Physician

Contact details

Address
Institute of Applied Health Research
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Alice’s research interests are predominantly in clinical aspects of alpha 1 antitrypsin deficiency (AATD) and chronic obstructive pulmonary disease (COPD), fields in which she has published widely. Optimising monitoring and therapy for AATD is a major focus for her group. They are also studying aspects of care delivery for COPD, particularly those that span from secondary into primary care and including clinical trials that optimise self-management of COPD.

Qualifications

  • FRCP 2020
  • PGDip Leadership & quality improvement 2019
  • PhD in Respiratory Medicine 2010
  • PGC in Medical Education 2007
  • MRCP 2004
  • MBChB (Hons) 2001

Teaching

PG Cert in Respiratory Medicine

MBChB (year 5 lead, conference poster module lead (year 4))

BMedSci (dissertation projects)

BClinSci (dissertation projects)

PGC/Dip/Masters Respiratory Medicine (Programme lead)

Postgraduate supervision

Alice Turner’s research interests are predominantly in chronic obstructive pulmonary disease and alpha 1 antitrypsin deficiency, fields in which she has published widely. She lectures to both Medical and Dental Students at the University and is involved in clinical teaching and examining in several local hospitals.

The following is a list of recent or current postgraduate degree supervision. Enquiries from self-funded potential students or those wishing to pursue a Fellowship in Dr Turner's current areas of research interest are welcome by email.

PhD - Cell specific genomics exploring shared pathogenesis between COPD and lung cancer (year 2)
PhD - The role of hypoxia in vascular co-morbidity in chronic inflammatory disease (write up)

Other activities

Academic/clinical committees

•           International

o          ERS AATD task force (2015-)

o          EARCO European AATD registry steering group (2018-)

o          Clinical Biomarker Qualification consortium, imaging subgroup (2018-)

•           National

o          BTS working party for care bundles (2013-14) 

o          BTS Specialist Advisory Group (SAG) on COPD (2015-18)

o          West Midlands Quality Review Service COPD steering group (2016-)

o          NICE health technology appraisal committee (2018-21)

o          NIHR HTA prioritization committee (2019-)

o          BTS quality improvement committee (2019-22)

Publications

Recent publications

Article

Adab, P, Jordan, R, Fitzmaurice, D, Ayres, J, Cheng, KK, Cooper, B, Daley, A, Dickens, A, Enocson, A, Greenfield, S, Haroon, S, Jolly, K, Jowett, S, Lambe, T, Martin, J, Miller, M, Rai, K, Riley, RD, Sadhra, S, Sitch, A, Siebert, S, Stockley, RA & Turner, A 2020, 'Chronic obstructive pulmonary disease in primary care; from case finding to improving patient outcomes: the Birmingham Lung Improvement Studies (BLISS) research programme', ERO .

Quinn, M & Turner, A 2020, 'Modernising case finding for Alpha-1-antitrypsin deficiency by DNA sequencing of COPD patients', The European respiratory journal.

García Castillo, E, Alonso Pérez, T, Ancochea, J, Pastor-Sanz, TM, Almagro, P, Martinez-Camblor, P, Rodriguez-Carballeira, M, Navarro, A, Lamprecht, B, Sofia Ramírez, A, Kaiser, B, Alfageme, I, Casanova, C, Esteban, C, Soler Cataluña, JJ, Celli, B, Marin, JM, Ter Riet, G, Sobradillo, P, Lange, P, Garcia-Aymerich, J, Antó, JM, Turner, A, Han, M, Langhammer, A, Vikjord, SA, Sternberg, A, Leivseth, L, Bakke, P, Johannessen, A, Oga, T, Cosio, B, IdISBa, CIBERES, Echazarreta, A, Roche, N, Burgel, P-R, Sin, D, Puhan, M, Lopez-Campos, JL, Carrasco, L & Soriano, JB 2020, 'Mortality prediction in chronic obstructive pulmonary disease comparing GOLD2015 and GOLD2019 staging:a pooled analysis of individual patient data', The European respiratory journal.

Chukowry, P, Edgar, R & Turner, A 2019, 'Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung', Expert Opinion on Orphan Drugs, vol. 7, no. 7-8, pp. 315-326. https://doi.org/10.1080/21678707.2019.1651640

Horvath, I, Canotilho, M, Chlumský, J, Chorostowska-Wynimko, J, Corda, L, Derom, E, Ficker, JH, Kneussl, M, Miravitlles, M, Sucena, M, Thabut, G, Turner, A, van ’t Wout, E & McElvaney, NG 2019, 'Diagnosis and management of Alpha 1 Antitrypsin deficiency in Europe: an expert survey', ERJ Open Research, vol. 5, no. 1. https://doi.org/10.1183/23120541.00171-2018

Pye, A & Turner, A 2019, 'Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency', Expert opinion on investigational drugs, vol. 28, no. 10, pp. 891-902. https://doi.org/10.1080/13543784.2019.1672656

Almagro, P, Turner, A, Martinez-Camblor, P, Miravitlles, M, Navarro, A, Lamprecht, B, Ramírez-García, S, Kaiser, B, Casanova, C, Alfageme, I, Esteban, C, de Torres, J, Soler-Cataluña, JJ, Marin, J, Celli, B, Ter Riet, G, Sobradillo, P, Lange, P, Garcia-Aymerich, J, Josep, A, Han, MK, Langhammer, A, Steinberg, A, Leivseth, L, Bakke, P, Johannessen, A, Oga, T, Cosio, B, Ancochea, J, Echazarreta, A, Roche, N, Burgel, P-R, Sin, D, Puhan, M & Soriano, J 2019, 'External validation and recalculation of the CODEX index in COPD patients: A 3CIAplus cohort study', COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 16, no. 1, pp. 8-17. https://doi.org/10.1080/15412555.2018.1484440

Keene , SJ, Jordan, R, Franssen, FME, de Vries, F, Martin, J, Sitch, A, Turner, A, Dickens, A, Fitzmaurice, D & Adab, P 2019, 'External validation of the updated ADO score in COPD patients from the Birmingham COPD cohort', International journal of chronic obstructive pulmonary disease, vol. 14, pp. 2395—2407. https://doi.org/10.2147/COPD.S212381

Trethewey, S, Brown, N, Gao Smith, F & Turner, A 2019, 'Interventions for the management and prevention of sarcopenia in the critically ill: a systematic review', Journal of Critical Care, vol. 50, pp. 287-295. https://doi.org/10.1016/j.jcrc.2019.01.008

Trethewey, S, Edgar, R, Morlet, J, Mukherjee, R & Turner, A 2019, 'Late presentation of acute hypercapnic respiratory failure carries a high mortality risk in COPD patients treated with ward-based NIV', Journal of Respiratory Medicine, vol. 151, pp. 128-132. https://doi.org/10.1016/j.rmed.2019.04.013

Lambe, T, Adab, P, Jordan, R, Sitch, A, Enocson, A, Jolly, K, Marsh, J, Riley, RD, Miller, M, Cooper, BG, Turner, A, Ayres, J, Stockley, RA, Greenfield, S, Siebert, S, Daley, A, Cheng, K, Fitzmaurice, D & Jowett, S 2019, 'Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care', Thorax, vol. 74, pp. 730-739. https://doi.org/10.1136/thoraxjnl-2018-212148

Trethewey, S, Edgar, R, Morlet, J, Mukherjee, R & Turner, A 2019, 'Temporal trends in survival following ward-based NIV for acute hypercapnic respiratory failure in patients with COPD', The Clinical Respiratory Journal, vol. 13, no. 3, pp. 184-188.

Abstract

Ubhi, G, Mason, J & Turner, A 2019, 'Exploring cost awareness as an influence on prescribing behaviours in secondary care: a mixed methods study', International Journal of Pharmacy Practice, vol. 27, no. S2. https://doi.org/10.1111/ijpp.12533

Editorial

Madan, A & Turner, A 2019, 'Identifying the at risk smokers: who goes on to get COPD?', The European respiratory journal, vol. 54, no. 4, 1901613. https://doi.org/10.1183/13993003.01613-2019

Review article

Rangaraju, M & Turner, A 2020, 'Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors', Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, pp. 280-289. https://doi.org/10.15326/jcopdf.7.3.2019.0177

View all publications in research portal